134 related articles for article (PubMed ID: 9639406)
21. Characterization of a human colorectal carcinoma cell line with acquired resistance to flavopiridol.
Smith V; Raynaud F; Workman P; Kelland LR
Mol Pharmacol; 2001 Nov; 60(5):885-93. PubMed ID: 11641415
[TBL] [Abstract][Full Text] [Related]
22. Flavopiridol: pleiotropic biological effects enhance its anti-cancer activity.
Newcomb EW
Anticancer Drugs; 2004 Jun; 15(5):411-9. PubMed ID: 15166614
[TBL] [Abstract][Full Text] [Related]
23. Flavopiridol as a radio-sensitizer for esophageal cancer cell lines.
Sato S; Kajiyama Y; Sugano M; Iwanuma Y; Tsurumaru M
Dis Esophagus; 2004; 17(4):338-44. PubMed ID: 15569374
[TBL] [Abstract][Full Text] [Related]
24. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis.
Wittmann S; Bali P; Donapaty S; Nimmanapalli R; Guo F; Yamaguchi H; Huang M; Jove R; Wang HG; Bhalla K
Cancer Res; 2003 Jan; 63(1):93-9. PubMed ID: 12517783
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: activation of the mitochondria-dependent death-signaling pathway.
Nguyen DM; Schrump WD; Tsai WS; Chen A; Stewart JH; Steiner F; Schrump DS
J Thorac Cardiovasc Surg; 2003 May; 125(5):1132-42. PubMed ID: 12771887
[TBL] [Abstract][Full Text] [Related]
26. Flavopiridol induces apoptosis in B-cell chronic lymphocytic leukaemia cells through a p38 and ERK MAP kinase-dependent mechanism.
Pepper C; Thomas A; Fegan C; Hoy T; Bentley P
Leuk Lymphoma; 2003 Feb; 44(2):337-42. PubMed ID: 12688354
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of action of flavopiridol.
Sedlacek HH
Crit Rev Oncol Hematol; 2001 May; 38(2):139-70. PubMed ID: 11311660
[TBL] [Abstract][Full Text] [Related]
28. Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells.
Schrump DS; Matthews W; Chen GA; Mixon A; Altorki NK
Clin Cancer Res; 1998 Nov; 4(11):2885-90. PubMed ID: 9829756
[TBL] [Abstract][Full Text] [Related]
29. CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer cells compared to flavopiridol.
Liu X; Shi S; Lam F; Pepper C; Fischer PM; Wang S
Int J Cancer; 2012 Mar; 130(5):1216-26. PubMed ID: 21484792
[TBL] [Abstract][Full Text] [Related]
30. Flavopiridol Induces Apoptosis via Mitochondrial Pathway in B16F10 Murine Melanoma Cells and a Subcutaneous Melanoma Tumor Model.
Gokce O; Dogan Turacli I; Ilke Onen H; Erdem O; Erguven Kayaa E; Ekmekci A
Acta Dermatovenerol Croat; 2016 Apr; 24(1):2-12. PubMed ID: 27149123
[TBL] [Abstract][Full Text] [Related]
31. Flavopiridol, a cyclin dependent kinase (CDK) inhibitor, induces apoptosis by regulating Bcl-x in oral cancer cells.
Mihara M; Shintani S; Nakashiro K; Hamakawa H
Oral Oncol; 2003 Jan; 39(1):49-55. PubMed ID: 12457721
[TBL] [Abstract][Full Text] [Related]
32. Effects of flavopiridol on critical regulation pathways of CD133high/CD44high lung cancer stem cells.
Bozok Cetintas V; Acikgoz E; Yigitturk G; Demir K; Oktem G; Tezcanli Kaymaz B; Oltulu F; Aktug H
Medicine (Baltimore); 2016 Oct; 95(43):e5150. PubMed ID: 27787370
[TBL] [Abstract][Full Text] [Related]
33. Rhabdoid tumor growth is inhibited by flavopiridol.
Smith ME; Cimica V; Chinni S; Challagulla K; Mani S; Kalpana GV
Clin Cancer Res; 2008 Jan; 14(2):523-32. PubMed ID: 18223228
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].
Song Y; Shen K; Tang PP
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):761-4. PubMed ID: 18307904
[TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
Dai Y; Rahmani M; Grant S
Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
[TBL] [Abstract][Full Text] [Related]
36. Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells.
Ali S; El-Rayes BF; Aranha O; Sarkar FH; Philip PA
Breast Cancer Res Treat; 2005 Mar; 90(1):25-31. PubMed ID: 15770523
[TBL] [Abstract][Full Text] [Related]
37. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
[TBL] [Abstract][Full Text] [Related]
38. The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines.
König A; Schwartz GK; Mohammad RM; Al-Katib A; Gabrilove JL
Blood; 1997 Dec; 90(11):4307-12. PubMed ID: 9373241
[TBL] [Abstract][Full Text] [Related]
39. Enhanced Anti-tumor Effect of Flavopiridol in Combination With Gemcitabine in Pancreatic Cancer.
Chung KH; Cho IR; Paik WH; Kim YT; Lee SH; Ryu JK
Anticancer Res; 2024 Mar; 44(3):1097-1108. PubMed ID: 38423644
[TBL] [Abstract][Full Text] [Related]
40. Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation.
Puppo M; Pastorino S; Melillo G; Pezzolo A; Varesio L; Bosco MC
Clin Cancer Res; 2004 Dec; 10(24):8704-19. PubMed ID: 15623656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
